Skip to content
FemOptimize

Magnesium for women over 40: what it does and doesn't help with

Magnesium is sold for sleep, anxiety, cramps, migraine, hot flashes and "hormone balance". I take it myself, so I went looking for what the trials found on each of those, one at a time.

By Marija MarjanovićCurious, skeptical, and sharing what I find

  • Published
  • Last reviewed
  • 28 sources

What made me curious

I take magnesium bisglycinate in the evening, and honestly, I love it. It started with a friend. I was telling her how my mind just wouldn’t switch off at bedtime, and she said I should try magnesium. I did, and in my experience it has helped both my sleep and my anxiety. It completely worked for me.

Then I started reading about it, and I was a bit startled by how much magnesium is supposed to do, especially once you pass a certain age: sleep, anxiety, leg cramps, migraine, hot flashes, bones, and something called “hormone balance”. So I went through those one at a time to see which ones the research has actually tested. I included the one I care about most, because my own experience is a single data point, and I wanted to see how it sits next to the trials.

What magnesium is, roughly

Magnesium is a mineral involved in hundreds of processes in the body, including nerve signalling and muscle contraction. You get it from food: pumpkin seeds, chia, almonds and spinach are among the richest sources. The recommended daily amount for women over 31 is 320 mg from all sources combined, according to the US Office of Dietary Supplements.

Supplements come as different “salts” (glycinate, citrate, oxide, threonate and others). That matters for how well they’re absorbed and, possibly, for what they do. I come back to it further down.

Does magnesium help you sleep?

This is the claim you’ll see most often, and it’s usually backed by a 2021 meta-analysis. It’s also the one I was most curious about.

Magnesium helped older adults fall asleep about 17 minutes faster than placebo, but total sleep time didn't change significantly and the certainty of the evidence was low to very low.

Mah & Pitre, BMC Complementary Medicine and Therapies, 20213 randomised trials · 151 older adultsLimited

That figure is real, but it rests on three small trials in older adults. They used magnesium oxide and citrate. Two of the three also used doses well above 350 mg a day, which is the US upper limit for supplements (they used 500 mg and 729 mg). I’ll admit that surprised me, given how often this study gets quoted.

A 2026 review of twelve trials took a wider look. It found the results inconsistent across questionnaires, sleep recordings and wearables. Its authors concluded that the evidence doesn’t support magnesium as a routine insomnia treatment, though they left room for a modest benefit in some people.

What about glycinate specifically?

I’d been wondering about exactly this, because it’s what I take. None of the trials in the 2021 meta-analysis used glycinate. There is one placebo-controlled trial of bisglycinate for sleep, published in 2025.

Magnesium bisglycinate, 250 mg a day for four weeks, reduced insomnia scores slightly more than placebo: a small effect that only just reached statistical significance.

Schuster et al., Nature and Science of Sleep, 2025155 adults aged 18–65 with poor sleep · p = 0.049Limited

Two details caught my eye. First, in an exploratory analysis, people who ate less magnesium to begin with seemed to benefit more. That would fit the idea that it helps most if you’re low.

Second, there’s a plausible reason glycinate might behave differently. Glycine, the amino acid it’s bound to, has its own small set of sleep trials. A 2026 review found only three, all reporting some benefit, and they used about 3 g of glycine. By my own rough arithmetic, a 250 mg dose of magnesium as bisglycinate carries about half that. Nobody has tested whether the glycine in glycinate does anything, so this is a hypothesis rather than evidence. I like the idea, though, and I’d love someone to test it.

I also looked for trials in women going through the menopause. The only one I found tested a combination product containing magnesium, made by the company that ran the trial. So it can’t tell us about magnesium on its own.

So where does that leave me? As far as I can tell, both things are true at once. The evidence for magnesium and sleep is limited, and it really did help me. A small average effect in a trial can hide people who respond a lot and people who don’t respond at all, and a trial can’t tell any one of us which group we’re in. My experience doesn’t prove anything about magnesium, and the trials don’t disprove what I noticed.

Does it help with anxiety?

This one matters to me too, since it’s the other thing I noticed. The main review pooled eighteen studies, all in people who were already anxious or had premenstrual symptoms. About half reported benefits. The reviewers called the evidence suggestive but of poor quality, and none of the studies used a validated stress measure. I couldn’t find anything done in perimenopausal women. To me it reads as a real signal that simply hasn’t been tested well yet, so the question is still open.

Does it prevent night-time leg cramps?

This is the best-studied question in the whole topic, which I didn’t expect. The trials mostly point towards little or no benefit.

Magnesium is unlikely to give older adults clinically meaningful protection against muscle cramps.

Garrison et al., Cochrane Database of Systematic Reviews, 202011 randomised trials · 735 people · moderate certaintyStrong evidence

A 2026 Finnish trial in adults aged 50 to 85, mostly women, found the same. Magnesium did no better than placebo, while compression stockings did help. One 2021 trial of a specific magnesium oxide product was positive, though the difference was under one cramp a week.

The one I found most useful was a 2017 trial in which cramps fell by about 40 per cent in both groups, placebo included. That made a lot of sense to me. If cramps often ease on their own, it’s easy to see why so many people feel magnesium works.

Does it prevent migraine?

I didn’t see this coming, but migraine turned out to be magnesium’s best-supported use. A 2012 guideline from the American Academy of Neurology and American Headache Society rated it “probably effective”. A stricter 2018 review said “possibly effective”. A 2016 meta-analysis of ten trials found fewer and less intense migraines.

The trials are small, mostly used around 600 mg a day, and weren’t done in perimenopausal women. Clinicians have used magnesium for migraine for years, and practice may well be ahead of the trials here. If migraine is your reason for considering it, a dose above the supplement upper limit is something to discuss with whoever treats your headaches.

Does it help hot flashes?

I was curious where this claim came from. It traces back to a small 2011 pilot in breast cancer survivors, where hot flashes fell by about 40 per cent. That pilot had no placebo group. The controlled trial that followed, in 289 women, found no difference between magnesium oxide and placebo.

In fairness, that trial used a poorly absorbed form, at high doses, in women who’d had breast cancer, many of them on hormone-blocking treatment. That’s a different situation from a typical woman in perimenopause, and nobody has tested magnesium alone for hot flashes in that group. A Mayo Clinic trial of glycinate finished in 2021. I looked, and I couldn’t find its results anywhere, which I find a little frustrating.

The other claims

Blood pressure: a 2025 meta-analysis of 38 trials found reductions of about 3 mmHg, mostly in people with high blood pressure. Bone: in 73,684 postmenopausal women, higher intake went with slightly higher hip bone density, but not with fewer fractures. That comes from an observational study, so it shows an association only. Threonate for sleep and the brain: the trials are small and run or funded by companies in the threonate business. One, in adults aged 35 to 55, reported better ring-measured sleep over three weeks. Another found a small cognition benefit but no change in ring-measured sleep. “Balances hormones” or lowers cortisol: I looked hard for this one, and I couldn’t find a single human trial in midlife women.

Which form, and how much?

Citrate absorbed better than oxide in a small study of fourteen men. Oxide is cheap, poorly absorbed and more likely to loosen your stools, and it’s the form used in most of the negative trials. Whether those trials failed because of the oxide is a reasonable hypothesis, but nobody has tested it.

Glycinate is the form in the one sleep trial. You’ll read everywhere that it’s gentler on the gut, and I was surprised to find no study showing that. A 2019 study also found that the specific product mattered as much as the salt: two commercial supplements differed roughly twentyfold in absorption.

The US upper limit for supplemental magnesium is 350 mg a day, and food doesn’t count towards it. The EU’s figure is lower, at 250 mg. The limit is based on diarrhoea, and above it the main problems are digestive. People with reduced kidney function are at greater risk and should talk to a doctor first. Magnesium may interact with osteoporosis drugs called bisphosphonates and with tetracycline and quinolone antibiotics. Diuretics and proton pump inhibitors can lower your magnesium too, so it’s worth asking a pharmacist about timing.

As for testing, a normal blood result doesn’t settle much. The Office of Dietary Supplements says blood levels don’t accurately reflect the magnesium in your body as a whole. A review by one of its researchers suggests combining a blood test with a 24-hour urine test and a look at your diet.

What clinicians say

Clinicians and practitioners who work with a lot of women in perimenopause commonly recommend magnesium in the evening, for sleep and for a mind that won’t settle at night. That’s more or less how it came to me too, through a friend rather than a doctor. They don’t all favour the same form: some suggest glycinate, and some suggest threonate. Their view comes from years of seeing what helps the women in front of them, and I think that’s worth taking seriously.

Beyond the trials above, I couldn’t find studies that settle which form is best, or that test magnesium on its own for perimenopausal sleep. That doesn’t mean the clinicians are wrong. Trials take years and money, and in women’s health a lot of them simply haven’t been done yet. You can decide whether that clinical experience is enough for you, or whether you’d rather wait for stronger studies.

What this means in practice

If you want to try magnesium, food first is sensible, and supplements up to 350 mg a day look low-risk if your kidneys are healthy. Citrate absorbed better than oxide in the one small comparison I found. For migraine, the evidence is reasonable. For sleep and anxiety it’s limited, and some people, me included, find it helps. For leg cramps and hot flashes, the trials that exist didn’t find a benefit. There’s more on how we weigh all this on how we research, and other supplements are in the supplements section.

What I decided

I’m still taking my bisglycinate in the evening, and I’m happy about that. After reading all this, I take it knowing the evidence for sleep is thin, and that what I’ve noticed is my own experience rather than proof. It’s inexpensive, and it helps me wind down when my head is still busy at bedtime. That’s enough for me, and I can see why someone looking at the same trials would decide otherwise. If you’re new to this, Start here explains the bigger picture, and the creatine review is an example of a supplement with considerably stronger evidence behind it.

What I still don’t know

  • Whether magnesium alone helps perimenopausal sleep, mood or hot flashes. A Northumbria University trial in women aged 40 to 60 is finishing about now, and its results could change this page.
  • Whether the form matters for outcomes. No trial has compared forms on sleep, anxiety or cramps.
  • Whether the glycine in glycinate contributes, or whether that’s a neat idea that won’t hold.
  • Who responds. Hints suggest people with low magnesium benefit more, but testing is unreliable.
  • What the unpublished Mayo Clinic hot flash trial found.

If any of that changes, I’ll come back and update this.

Where the evidence stands

  • Helps people fall asleep a little faster (magnesium in general; trials inconsistent)Limited
  • Magnesium bisglycinate slightly improves insomnia symptoms (one trial)Limited
  • Eases anxiety in people who are already anxious or have PMSLimited
  • Does not meaningfully prevent night-time leg cramps in older adultsStrong evidence
  • Helps prevent migraineModerate
  • Reduces hot flashes (the one controlled trial found no effect)Limited
  • Lowers blood pressure slightly, mainly in people with high blood pressureModerate
  • Higher intake linked to slightly higher hip bone density, but not to fewer fracturesLimited
  • Magnesium L-threonate improves memory, cognition or sleepLimited
  • "Balances hormones" or lowers cortisol in midlife womenInsufficient
  • Safe at up to 350 mg a day from supplements, in people with healthy kidneysStrong evidence

Sources

  1. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis BMC Complementary Medicine and Therapies. 2021. doi:10.1186/s12906-021-03297-z

    Three RCTs, 151 older adults. Sleep-onset latency 17.36 min shorter than placebo; total sleep time +16 min, not significant. Low to very low certainty. Forms were oxide and citrate, 320–729 mg elemental a day, two of the three trials above the 350 mg supplemental upper limit.

  2. Lopresti AL, Smith SJ, Drummond PD. Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials Journal of Dietary Supplements. 2026. doi:10.1080/19390211.2026.2719670

    Twelve RCTs on sleep. Findings inconsistent across questionnaires, EEG, actigraphy and wearables; certainty low to very low. Evidence does not support magnesium as a routine insomnia treatment; possible modest subjective benefit for some people.

  3. Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial Nature and Science of Sleep. 2025. doi:10.2147/NSS.S524348

    155 adults aged 18–65 with poor sleep; 250 mg elemental magnesium as bisglycinate or placebo for 4 weeks. Insomnia Severity Index fell 3.9 vs 2.3 points (p = 0.049; small effect, d = 0.2). Exploratory finding of larger benefit in people with low dietary magnesium.

  4. Fan Z, Nelson JM, Wallace TC. Glycine Bioavailability and Sleep-Related Outcomes Following Oral Glycine and Collagen Supplementation — A Scoping Review Journal of Dietary Supplements. 2026. doi:10.1080/19390211.2026.2726197

    Only three trials of supplemental glycine on sleep; all reported benefit on at least one outcome. Body-temperature and NMDA pathways plausible; not directly tested.

  5. Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review Nutrients. 2017. doi:10.3390/nu9050429

    18 studies, all in anxiety-vulnerable groups. Positive results in 4 of 8 mildly anxious and 4 of 7 PMS samples. Evidence suggestive but of poor quality; no validated stress measure used.

  6. Garrison SR, Korownyk CS, Kolber MR, Allan GM, Musini VM, Sekhon RK, Dugré N. Magnesium for skeletal muscle cramps Cochrane Database of Systematic Reviews. 2020. doi:10.1002/14651858.CD009402.pub3

    11 RCTs, 735 people. In mostly older adults, magnesium is unlikely to give clinically meaningful protection against cramps (moderate certainty). Gut side effects in 11–37% on magnesium vs 10–14% on control.

  7. Roguin Maor N, Alperin M, Shturman E, Khairaldeen H, Friedman M, Karkabi K, Milman U. Effect of Magnesium Oxide Supplementation on Nocturnal Leg Cramps: A Randomized Clinical Trial JAMA Internal Medicine. 2017. doi:10.1001/jamainternmed.2016.9261

    94 adults, magnesium oxide or placebo at bedtime for 4 weeks. Cramps fell in both groups (−3.41 vs −3.03 a week; no significant difference).

  8. Kuusipalo A, Laitila J, Lehtonen E, Joensuu J, Mustajoki P, Mustonen P, Huhtala H, Kaila M, Koskela TH. Secondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial Trials. 2026. doi:10.1186/s13063-025-09370-z

    121 adults aged 50–85, 72% women. Magnesium no better than placebo (−0.20 cramps a week, p = 0.929); compression stockings beat placebo (−1.43 a week).

  9. Barna O, Lohoida P, Holovchenko Y, Bazylevych A, Velychko V, Hovbakh I, Bula L, Shechter M. A randomized, double-blind, placebo-controlled, multicenter study assessing the efficacy of magnesium oxide monohydrate in the treatment of nocturnal leg cramps Nutrition Journal. 2021. doi:10.1186/s12937-021-00747-9

    175 completers; one magnesium oxide monohydrate product, 226 mg at bedtime for 60 days. Episodes fell −3.4 vs −2.6 a week (p = 0.01). Registered retrospectively.

  10. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E (AAN Quality Standards Subcommittee and American Headache Society). Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults Neurology. 2012. doi:10.1212/WNL.0b013e3182535d0c

    Rates magnesium "probably effective" (Level B) for preventing migraine. Evidence reviewed 1999–2009.

  11. von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis — Is There an Evidence-Based Rationale? A Systematic Review Headache. 2018. doi:10.1111/head.13217

    Five double-blind RCTs. Overall "possibly effective" (Grade C); high-dose magnesium dicitrate (600 mg) suggested as safe and inexpensive.

  12. Chiu HY, Yeh TH, Huang YC, Chen PY. Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials Pain Physician. 2016. PMID 26752497

    10 oral-prevention RCTs, 789 participants. Oral magnesium reduced migraine frequency and intensity; some trials had inadequate randomisation.

  13. Park H, Parker GL, Boardman CH, Morris MM, Smith TJ. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients Supportive Care in Cancer. 2011. doi:10.1007/s00520-011-1099-7

    Single-arm pilot with no placebo group; 25 women completed. Hot flash frequency fell 41.4% over 4 weeks on magnesium oxide.

  14. Park H, Qin R, Smith TJ, Atherton PJ, Barton DL, Sturtz K, Dakhil SR, Anderson DM, Flynn K, Puttabasavaiah S, Le-Lindqwister NA, Padula GD, Loprinzi CL. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes Menopause. 2015. doi:10.1097/GME.0000000000000374

    289 postmenopausal women with a history of breast cancer; magnesium oxide 800 or 1,200 mg a day vs placebo. Hot flashes similar in all groups; more diarrhoea on magnesium.

  15. Mayo Clinic (sponsor). Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes (NCT03564665) ClinicalTrials.gov. 2021. Source

    Randomised glycinate vs placebo trial in women with or at high risk of breast cancer; 40 enrolled, completed April 2021. No results posted or published.

  16. Northumbria University (sponsor). 12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being (NCT07235878) ClinicalTrials.gov. 2025. Source

    Women aged 40–60, magnesium hydroxide 375 mg vs placebo for 12 weeks, about 58 participants. No results yet.

  17. Carbonneau S, Mysliwiec V, Doyle AL, Stratton M, Dweck A, Tartar J, Alesi M, Mason L, Komorowski J, VanDusseldorp TA. Nonsedating neurotransmitter-modulating supplement for nonvasomotor sleep disturbance in menopause Menopause. 2026. doi:10.1097/GME.0000000000002880

    128 peri- and postmenopausal women; a multi-ingredient product containing magnesium vs placebo for 3 weeks improved sleep disturbance scores. Six authors employed by the manufacturer. Cannot isolate magnesium's effect.

  18. Argeros Z, Xu X, Bhandari B, Harris K, Touyz RM, Schutte AE. Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Hypertension. 2025. doi:10.1161/HYPERTENSIONAHA.125.25129

    38 RCTs, 2,709 participants. Systolic −2.81 and diastolic −2.05 mmHg vs placebo; larger in treated hypertension, not significant in people with normal blood pressure.

  19. Orchard TS, Larson JC, Alghothani N, Bout-Tabaku S, Cauley JA, Chen Z, LaCroix AZ, Wactawski-Wende J, Jackson RD. Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study American Journal of Clinical Nutrition. 2014. doi:10.3945/ajcn.113.067488

    73,684 postmenopausal women. Hip bone density 3% higher at the highest vs lowest intakes; no difference in hip or total fractures. An association only.

  20. Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, Gu J. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial Sleep Medicine X. 2024. doi:10.1016/j.sleepx.2024.100121

    80 adults aged 35–55; 1 g a day magnesium L-threonate or placebo for 21 days. Ring-measured deep and REM sleep scores improved. Three of six authors from AIDP, Inc., which holds the copyright.

  21. Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial Frontiers in Nutrition. 2026. doi:10.3389/fnut.2025.1729164

    100 adults aged 18–45, 6 weeks. Total cognition score improved (p = 0.043); one questionnaire sleep measure improved, ring-measured sleep did not. Funded by Threotech Inc., which supplied the product.

  22. Werner T, Kolisek M, Vormann J, Pilchova I, Grendar M, Struharnanska E, Cibulka M. Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects Magnesium Research. 2019. doi:10.1684/mrh.2019.0457

    14 healthy men, a single 400 mg dose. Citrate raised urinary and blood magnesium significantly; oxide did not.

  23. Blancquaert L, Vervaet C, Derave W. Predicting and Testing Bioavailability of Magnesium Supplements Nutrients. 2019. doi:10.3390/nu11071663

    15 commercial products varied widely in the lab; the best and worst, tested in 30 people, differed roughly twentyfold in absorption.

  24. Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — Chapter 6: Magnesium National Academy Press. 1997. Source

    RDA 320 mg a day for women 31+. Upper limit 350 mg a day from supplements, based on diarrhoea. Impaired kidney function raises the risk of toxicity. Clinicians may prescribe more for specific conditions.

  25. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, et al.. Safety of magnesium L-threonate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of magnesium from this source EFSA Journal. 2024. doi:10.2903/j.efsa.2024.8656

    Confirms the EU upper level of 250 mg a day of supplemental magnesium from readily dissociable salts, on top of diet; adequate intake 300 mg a day for women.

  26. NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals National Institutes of Health. 2026. Source

    Upper limit 350 mg a day of supplemental magnesium for adults; RDA 320 mg for women 31+. May interact with bisphosphonates, tetracycline and quinolone antibiotics; diuretics and proton pump inhibitors can affect magnesium status. Serum magnesium does not accurately reflect total body magnesium.

  27. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S, Erickson SB. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies Renal Failure. 2015. doi:10.3109/0886022X.2015.1057800

    Nine observational studies, 109,798 patients. Proton pump inhibitor use associated with a 43% higher risk of low magnesium.

  28. Costello RB, Nielsen F. Interpreting magnesium status to enhance clinical care: key indicators Current Opinion in Clinical Nutrition and Metabolic Care. 2017. doi:10.1097/MCO.0000000000000410

    A serum result at the low end of normal may still mean deficiency when other risk factors are present; best practical assessment combines blood, 24-hour urine and diet.